215 related articles for article (PubMed ID: 25502635)
41. High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.
Hyun SY; Cheong JW; Kim SJ; Min YH; Yang DH; Ahn JS; Lee WS; Ryoo HM; Do YR; Lee HS; Lee JH; Oh SY; Suh C; Yhim HY; Kim JS
Biol Blood Marrow Transplant; 2014 Jan; 20(1):73-9. PubMed ID: 24141009
[TBL] [Abstract][Full Text] [Related]
42. Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.
Hohloch K; Sahlmann CO; Lakhani VJ; Wulf G; Glass B; Hasenkamp J; Meller J; Riggert J; Trümper L; Griesinger F
Ann Hematol; 2011 Nov; 90(11):1307-15. PubMed ID: 21360108
[TBL] [Abstract][Full Text] [Related]
43. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
44. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
[TBL] [Abstract][Full Text] [Related]
45. Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma.
Friedberg JW; Kim H; Li S; Neuberg D; Boyd K; Daley H; Fisher DC; Gribben JG; Spitzer T; Freedman AS
Bone Marrow Transplant; 2003 Oct; 32(7):681-6. PubMed ID: 13130315
[TBL] [Abstract][Full Text] [Related]
46. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.
Freedman AS; Gribben JG; Neuberg D; Mauch P; Soiffer RJ; Anderson KC; Pandite L; Robertson MJ; Kroon M; Ritz J; Nadler LM
Blood; 1996 Oct; 88(7):2780-6. PubMed ID: 8839876
[TBL] [Abstract][Full Text] [Related]
47. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
Leger C; Sabloff M; McDiarmid S; Bence-Bruckler I; Atkins H; Bredeson C; Zhang H; Huebsch L
Ann Hematol; 2006 Oct; 85(10):723-9. PubMed ID: 16832675
[TBL] [Abstract][Full Text] [Related]
48. Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.
Luminari S; Marcheselli L; Sacchi S; Pozzi S; Bari A; Ilariucci F; Stelitano C; Angrilli F; Lazzaro A; Baldini L
Cancer; 2009 May; 115(9):1906-13. PubMed ID: 19248044
[TBL] [Abstract][Full Text] [Related]
49. Autologous stem cell transplantation for untreated transformed indolent B-cell lymphoma in first remission: an international, multi-centre propensity-score-matched study.
Chin CK; Lim KJ; Lewis K; Jain P; Qing Y; Feng L; Cheah CY; Seymour JF; Ritchie D; Burbury K; Tam CS; Fowler NH; Fayad LE; Westin JR; Neelapu SS; Hagemeister FB; Samaniego F; Flowers CR; Nastoupil LJ; Dickinson MJ
Br J Haematol; 2020 Dec; 191(5):806-815. PubMed ID: 33065767
[TBL] [Abstract][Full Text] [Related]
50. [Leukemization of follicular lymphoma: The features of diagnostic and clinical course of a rare form of the disease].
Nesterova ES; Kravchenko SK; Mangasarova YK; Plastinina LV; Dvirnyk VN; Kovrigina AM; Shchupletsova IA; Obukhova TN; Gemdzhian EG; Vorobyev IA; Vorobyev AI
Ter Arkh; 2017; 89(7):45-50. PubMed ID: 28766540
[TBL] [Abstract][Full Text] [Related]
51. The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma.
Andresen S; Brandt J; Dietrich S; Memmer ML; Ho AD; Witzens-Harig M
Leuk Lymphoma; 2012 Mar; 53(3):386-93. PubMed ID: 21864036
[TBL] [Abstract][Full Text] [Related]
52. Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial.
Ladetto M; Tavarozzi R; Zanni M; Evangelista A; Ferrero S; Tucci A; Botto B; Bolis S; Volpetti S; Zilioli VR; Puccini B; Arcari A; Pavone V; Gaidano G; Corradini P; Tani M; Cavallo F; Milone G; Ghiggi C; Pinto A; Pastore D; Ferreri AJM; Latte G; Patti C; Re F; Benedetti F; Luminari S; Pennese E; Bossi E; Boccomini C; Anastasia A; Bottelli C; Ciccone G; Vitolo U
Ann Oncol; 2024 Jan; 35(1):118-129. PubMed ID: 37922989
[TBL] [Abstract][Full Text] [Related]
53. Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.
Lenz G; Dreyling M; Schiegnitz E; Forstpointner R; Wandt H; Freund M; Hess G; Truemper L; Diehl V; Kropff M; Kneba M; Schmitz N; Metzner B; Pfirrmann M; Unterhalt M; Hiddemann W;
Blood; 2004 Nov; 104(9):2667-74. PubMed ID: 15238420
[TBL] [Abstract][Full Text] [Related]
54. [Current treatment of follicular lymphoma].
Bonnet C; Beguin Y; Deprijck B; de Leval L; Fillet G
Rev Med Suisse; 2009 Aug; 5(214):1663-7. PubMed ID: 19772198
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.
Wrench D; Montoto S
Nat Rev Clin Oncol; 2010 Dec; 7(12):677-8. PubMed ID: 21116237
[No Abstract] [Full Text] [Related]
56. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.
Horning SJ; Negrin RS; Hoppe RT; Rosenberg SA; Chao NJ; Long GD; Brown BW; Blume KG
Blood; 2001 Jan; 97(2):404-9. PubMed ID: 11154216
[TBL] [Abstract][Full Text] [Related]
57. Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity.
Phipps C; Gopal AK; Storer BE; Cassaday RD; Press OW; Till BG; Pagel JM; Palanca-Wessels MC; Philip M; Bensinger WI; Holmberg LA; Shustov AR; Green DJ; Chauncey T; Maloney DG; Libby EN
Leuk Lymphoma; 2015 Jan; 56(1):92-6. PubMed ID: 24707941
[TBL] [Abstract][Full Text] [Related]
58. High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.
Gyan E; Foussard C; Bertrand P; Michenet P; Le Gouill S; Berthou C; Maisonneuve H; Delwail V; Gressin R; Quittet P; Vilque JP; Desablens B; Jaubert J; Ramée JF; Arakelyan N; Thyss A; Moluçon-Chabrot C; Delépine R; Milpied N; Colombat P; Deconinck E;
Blood; 2009 Jan; 113(5):995-1001. PubMed ID: 18955565
[TBL] [Abstract][Full Text] [Related]
59. Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.
Puvvada SD; Stiff PJ; Leblanc M; Cook JR; Couban S; Leonard JP; Kahl B; Marcellus D; Shea TC; Winter JN; Li H; Rimsza LM; Friedberg JW; Smith SM
Br J Haematol; 2016 Sep; 174(5):686-91. PubMed ID: 27072903
[TBL] [Abstract][Full Text] [Related]
60. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
